Department of Experimental Therapeutics & Breast Medical Oncology, University of Texas MD Anderson Cancer Center, The Morgan Welch Inflammatory Breast Cancer Research Program, 1515 Holcombe Blvd, Houston, TX 77030, USA.
Future Oncol. 2011 Jan;7(1):25-30. doi: 10.2217/fon.10.177.
Inflammatory breast cancer (IBC) is the most aggressive and deadly form of breast cancer. In spite of the comprehensive multidisciplinary approach to the management of this disease, the prognosis remains dismal. Moreover, there have been no major advancements in understanding the etiology and biology of IBC and no significant improvements in the diagnosis of the disease. The International Inflammatory Breast Cancer Conference was established in 2008 with the intention of creating a forum for the discussion, collaboration and development of proposals and working hypotheses. Furthermore, the conference represented an opportunity to raise awareness regarding IBC. The second international conference reported on several new exciting projects based on work from investigators and research teams devoted to making a difference in the fight against this disease.
炎性乳腺癌（IBC）是最具侵袭性和致命性的乳腺癌形式。尽管采用了综合多学科方法来治疗这种疾病，但预后仍然不佳。此外，人们对 IBC 的病因和生物学仍没有重大的认识进展，也没有对该疾病的诊断进行重大改进。国际炎性乳腺癌会议于 2008 年成立，旨在为讨论、合作和提出建议及工作假设提供一个论坛。此外，该会议还提供了提高对 IBC 认识的机会。第二届国际会议报告了几个新的令人兴奋的项目，这些项目基于致力于改变这种疾病的斗争的研究人员和研究团队的工作。
